Insys Therapeutics, Inc. Research and Development Expense
Insys Therapeutics, Inc. reported Research and Development Expense of $10.52 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2019-05-13
- Insys Therapeutics, Inc. research and development expense for the quarter ending 2019-03-31 was $10.52M, a 14.17% decline year-over-year.
- Insys Therapeutics, Inc. research and development expense for the quarter ending 2018-12-31 was $14.36M, a 12.28% decline year-over-year.
- Insys Therapeutics, Inc. research and development expense for the quarter ending 2018-09-30 was $14.48M, a 25.93% decline year-over-year.
- Insys Therapeutics, Inc. research and development expense for the quarter ending 2018-06-30 was $16.47M, a 16.80% increase year-over-year.
- Insys Therapeutics, Inc. research and development expense for fiscal 2018 was $57.57M, a 8.55% decline from fiscal 2017.
- Insys Therapeutics, Inc. research and development expense for fiscal 2017 was $62.95M, a 14.83% decline from fiscal 2016.
- Insys Therapeutics, Inc. research and development expense for fiscal 2016 was $73.91M, a 30.17% increase from fiscal 2015.
- Insys Therapeutics, Inc. research and development expense for fiscal 2015 was $56.78M, a 71.36% increase from fiscal 2014.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $10.52M 10-Q · filed 2019-05-13 | $24.88M derived: sum of 2 quarters · filed 2019-05-13 | $39.36M derived: sum of 3 quarters · filed 2019-05-13 | $55.84M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-12-31 | $14.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $28.84M derived: sum of 2 quarters · filed 2019-03-13 | $45.31M derived: sum of 3 quarters · filed 2019-03-13 | $57.57M 10-K · filed 2019-03-13 | ||||
| 2018-09-30 | $14.48M 10-Q · filed 2018-11-09 | $30.96M derived: sum of 2 quarters · filed 2018-11-09 | $43.22M 10-Q · filed 2018-11-09 | $59.58M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-06-30 | $16.47M 10-Q · filed 2018-08-09 | $28.73M 10-Q · filed 2018-08-09 | $45.10M derived: sum of 3 quarters · filed 2019-05-13 | $64.65M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-03-31 | $12.26M 10-Q · filed 2019-05-13 | $28.63M derived: sum of 2 quarters · filed 2019-05-13 | $48.18M derived: sum of 3 quarters · filed 2019-05-13 | $62.28M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $16.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $35.92M derived: sum of 2 quarters · filed 2019-03-13 | $50.02M derived: sum of 3 quarters · filed 2019-03-13 | $62.95M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $19.55M 10-Q · filed 2018-11-09 | $33.66M derived: sum of 2 quarters · filed 2018-11-09 | $46.59M 10-Q · filed 2018-11-09 | $62.06M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | $14.10M 10-Q · filed 2018-08-09 | $27.04M 10-Q · filed 2018-08-09 | $42.51M derived: sum of 3 quarters · filed 2019-03-13 | $59.03M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | $12.93M 10-Q · filed 2018-05-10 | $28.41M derived: sum of 2 quarters · filed 2019-03-13 | $44.92M derived: sum of 3 quarters · filed 2019-03-13 | $67.81M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | $15.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $31.99M derived: sum of 2 quarters · filed 2019-03-13 | $54.88M derived: sum of 3 quarters · filed 2019-03-13 | $73.91M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $16.52M 10-Q · filed 2017-11-03 | $39.41M derived: sum of 2 quarters · filed 2017-11-03 | $58.44M 10-Q · filed 2017-11-03 | $59.94M 10-Q · filed 2016-11-03 | $74.50M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-06-30 | $22.89M 10-Q · filed 2017-08-07 | $41.92M 10-Q · filed 2017-08-07 | $43.42M 10-Q · filed 2016-08-05 | $57.98M derived: sum of 3 quarters · filed 2018-03-12 | $70.31M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-03-31 | $19.04M 10-Q · filed 2017-05-09 | $20.54M 10-Q · filed 2016-05-05 | $35.10M derived: sum of 2 quarters · filed 2018-03-12 | $47.42M derived: sum of 3 quarters · filed 2018-03-12 | $65.21M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2015-12-31 | $16.06M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-12 | $28.38M derived: sum of 2 quarters · filed 2018-03-12 | $46.18M derived: sum of 3 quarters · filed 2018-03-12 | $56.78M 10-K · filed 2018-03-12 | $55.28M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $12.32M 10-Q · filed 2016-11-03 | $30.12M derived: sum of 2 quarters · filed 2017-04-07 | $40.72M 10-Q/A · filed 2017-04-07 | $53.64M derived: sum of 4 quarters · filed 2017-04-07 | ||||
| 2015-06-30 | $17.80M 10-Q/A · filed 2017-04-07 | $28.40M 10-Q/A · filed 2017-04-07 | $41.32M derived: sum of 3 quarters · filed 2017-04-07 | $48.34M derived: sum of 4 quarters · filed 2017-04-07 | ||||
| 2015-03-31 | $10.60M 10-Q/A · filed 2017-04-07 | $23.52M derived: sum of 2 quarters · filed 2017-04-07 | $30.54M derived: sum of 3 quarters · filed 2017-04-07 | $39.73M derived: sum of 4 quarters · filed 2017-04-07 | ||||
| 2014-12-31 | $12.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-03 | $19.94M derived: sum of 2 quarters · filed 2017-04-03 | $29.13M derived: sum of 3 quarters · filed 2017-04-03 | $33.14M 10-K · filed 2017-04-03 | ||||
| 2014-09-30 | $7.02M 10-Q · filed 2015-11-05 | $16.21M derived: sum of 2 quarters · filed 2015-11-05 | $20.21M 10-Q · filed 2015-11-05 | $23.37M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $9.19M 10-Q · filed 2015-08-06 | $13.20M 10-Q · filed 2015-08-06 | $16.35M derived: sum of 3 quarters · filed 2016-02-29 | $18.09M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $4.01M 10-Q · filed 2015-05-11 | $7.16M derived: sum of 2 quarters · filed 2016-02-29 | $8.90M derived: sum of 3 quarters · filed 2016-02-29 | $10.82M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $4.89M derived: sum of 2 quarters · filed 2016-02-29 | $6.81M derived: sum of 3 quarters · filed 2016-02-29 | $8.50M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $1.74M 10-Q · filed 2014-11-12 | $3.66M derived: sum of 2 quarters · filed 2014-11-12 | $5.35M 10-Q · filed 2014-11-12 | $6.01M derived: sum of 4 quarters · filed 2014-11-12 | ||||
| 2013-06-30 | $1.92M 10-Q · filed 2014-08-12 | $3.61M 10-Q · filed 2014-08-12 | $4.27M derived: sum of 3 quarters · filed 2014-08-12 | $5.39M derived: sum of 4 quarters · filed 2014-08-12 | ||||
| 2013-03-31 | $1.69M 10-Q · filed 2014-05-14 | $2.35M derived: sum of 2 quarters · filed 2014-05-14 | $3.47M derived: sum of 3 quarters · filed 2014-05-14 | $5.16M derived: sum of 4 quarters · filed 2014-05-14 | ||||
| 2012-12-31 | $658.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $1.78M derived: sum of 2 quarters · filed 2014-03-05 | $3.47M derived: sum of 3 quarters · filed 2014-03-05 | $6.30M 10-K · filed 2014-03-05 | ||||
| 2012-09-30 | $1.12M 10-Q · filed 2013-11-12 | $2.81M derived: sum of 2 quarters · filed 2013-11-12 | $5.65M 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | $1.70M 10-Q · filed 2013-08-13 | $4.53M 10-Q · filed 2013-08-13 | ||||||
| 2012-03-31 | $2.83M 10-Q · filed 2013-06-05 |